PREP Act Amendment and Fall Vaccines - Pharmacy Impact
On August 4, 2021 the Eighth Amendment of the Declaration Under the Public Readiness and Emergency Preparedness (PREP) Act for Medical Countermeasures Against COVID-19 was issued. One week later the CDC and FDA announce approval of a 3rd dose of COVID vaccine for specific high risk patients that have completed their mRNA vaccine series. With influenza vaccine season approaching pharmacists have a lot to prepare for. Our interactive session will discuss:
-- How the Eighth Amendment to the PREP Act impacts immunizing pharmacists and their vaccine administration workflow.
-- Patient eligibility for the 3rd dose of mRNA COVID vaccine.
-- Documentation and billing of the 3rd dose of COVID vaccine.
-- Overlap of COVID booster and influenza vaccine patient demand.
With 10,000 pharmacies reaching 8 million+ patients monthly, RedSail Technologies is the leader in pharmacy software and data solutions and services – empowering pharmacy and transforming care. Part of the country’s most clinically advanced and financially sustainable pharmacy network, RedSail customers receive the integrated tools and connectivity needed for success, freeing them for patient care. RedSail's customers include community, long-term care, outpatient, HME/DME, and specialty pharmacies alongside pharma, payer, and strategic industry partners. We offer solutions for pharmacy operations, transactional and medical billing services, and patient engagement and education through our brands including PioneerRx®, Axys®, PowerLine®, and QS/1®.
This post is related to:
Personalized Wellness, Point-of-Care Services Long-Term Care Pharmacy Resources
